Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Clinical trial NCT04900818 · RECRUITING

Trial details

NCT number: NCT04900818
Sponsor: I-Mab Biopharma US Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Advanced Cancer Metastatic Cancer Gastric Cancer Gastroesophageal Junction Carcinoma Esophageal Adenocarcinoma PDAC - Pancreatic Ductal Adenocarcinoma Biliary Tract Cancer (BTC)

Start date: 2021-06-29
Primary completion: 2026-12-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.